Search clinical trials for: GSK1349572
Total 36 results
-
GlaxoSmithKlineShionogiCompletedHealthy VolunteerUnited States
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States, France, Spain, Canada, Italy
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States, France, Netherlands, Spain, Taiwan, Australia, Belgium, Russian Federation, Canada, United Kingdom, Mexico, Italy, South Africa, Romania, Argentina, Hungary, Poland, Chile, Greece, Brazil
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompleted
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency Virus IGermany, Spain, France, Australia, United States, Canada, United Kingdom, Italy, Russian Federation
-
GlaxoSmithKlineShionogiCompleted
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedHIV Infections | Healthy Subjects | Hepatic Impairment | Infection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareCompleted
-
Erasmus Medical CenterCompletedHuman Immunodeficiency VirusNetherlands
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
University of North Carolina, Chapel HillGlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
University of North Carolina, Chapel HillGlaxoSmithKlineCompletedHealthy Adult FemalesUnited States
-
GlaxoSmithKlineShionogiCompletedHealthy Subjects | Infection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineWithdrawnInfection, Human Immunodeficiency Virus IUnited States
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompleted
-
ViiV HealthcareShionogiCompletedInfections, Human Immunodeficiency Virus and HepatitisUnited States
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfections, Human Immunodeficiency Virus and TuberculosisUnited States
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineShionogiCompletedHealthy VolunteerUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfections, Human Immunodeficiency Virus and HerpesviridaeUnited States
-
Mylan Inc.ViiV HealthcareCompleted
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States, Spain, France, Germany, Italy, Russian Federation
-
University of LiverpoolViiV Healthcare; Makerere UniversityCompletedHIV | MalariaUganda
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareShionogiCompletedHealthy VolunteerUnited States
-
GlaxoSmithKlineShionogiCompletedHealthy VolunteerUnited States
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfections, Human Immunodeficiency Virus and HerpesviridaeUnited States
-
GlaxoSmithKlineShionogiCompleted
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
University of LiverpoolViiV Healthcare; Makerere UniversityCompletedPregnancy | HIVUganda, South Africa